Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Financing Cash Flow (annual) by Year
Financing Cash Flow (annual) ($M)
Novartis Financing Cash Flow (annual): -$14,867M in FY2025, up 26.6% from a year earlier.
Latest, FY2025
-14,867
Period ended Dec 31, 2025
Change on a year earlier
+26.6%
-11,742 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Reported in Postgres DB.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Financing Cash Flow (annual) ($M), annual FY2015–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-cf-financing
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.